As a key regulator of hepatic lipogenesis, SREBP-1c was suggested to be involved in the development of NAFLD by contributing to the onset of fatty liver phenotypes [18]. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.